TRINITY BIOTECH PLCTRIBEarnings & Financial Report
Nasdaq
TRIB Q2 2024 Key Financial Metrics
売上高
$30.5M
粗利益
$11.3M
営業利益
$-7.1M
純利益
$-10.1M
粗利益率
36.8%
営業利益率
-23.2%
純利益率
-33.0%
前年比成長
N/A
資金フロー
TRINITY BIOTECH PLC Q2 2024 Financial Summary
TRINITY BIOTECH PLC reported revenue of $30.5M for Q2 2024, with a net profit of $-10.1M (-33.0% margin). Cost of goods sold was $19.3M, operating expenses totaled $18.3M.
Key Financial Metrics
| Total Revenue | $30.5M |
|---|---|
| Net Profit | $-10.1M |
| Gross Margin | 36.8% |
| Operating Margin | -23.2% |
| Report Period | Q2 2024 |
損益計算書
| Q2 2024 | |
|---|---|
| 売上高 | $30.5M |
| 前年比成長 | N/A |
貸借対照表
| Q2 2024 | |
|---|---|
| 総資産 | $94.4M |
| 総負債 | $123.8M |
| 株主資本 | $-29.4M |
キャッシュフロー
| Q2 2024 | |
|---|---|
| 営業CF | $-3.9M |